Antibodies to alpha-synuclein and uses thereof Grant US-11827695-B2 United States of America 28 Nov 2023
Agents, uses and methods for the treatment of synucleinopathy Grant US-11542323-B2 United States of America 03 Jan 2023
Agents, uses and methods for the treatment of synucleinopathy Grant US-11524995-B2 United States of America 13 Dec 2022
Agents, uses and methods for the treatment of synucleinopathy Grant US-11421024-B2 United States of America 23 Aug 2022
Antibodies to alpha-synuclein and uses thereof Grant US-11142570-B2 United States of America 12 Oct 2021
Agents, uses and methods for the treatment of synucleinopathy Grant US-10889635-B2 United States of America 12 Jan 2021
Agents, uses and methods for the treatment of synucleinopathy Grant US-10800836-B2 United States of America 13 Oct 2020
Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation Grant US-10364286-B2 United States of America 30 Jul 2019
Antibodies for the treatment of synucleinopathy Grant US-10364285-B2 United States of America 30 Jul 2019
Antibodies for the treatment of synucleinopathy Grant US-10358482-B2 United States of America 23 Jul 2019
Antibodies for the treatment of synucleinopathy Grant US-10358484-B2 United States of America 23 Jul 2019
Antibodies for the treatment of synucleinopathy Grant US-10358483-B2 United States of America 23 Jul 2019
METHOD FOR IN VITRO DIAGNOSIS OF DEMENTIA WITH LEWY BODIES USING ALPHASYNUCLEIN GENE… Application WO-2016180726-A1 World Intellectual Property Organisation (WIPO) 17 Nov 2016
METHOD FOR IN VITRO DIAGNOSIS OF SYNUCLEINOPATHIES USING ALPHA-SYNUCLEIN GENE TRANSCRIPTS Application EP-3091087-A1 European Patent Office 09 Nov 2016